| Title | Onkológia
|
|---|
| Year, No. | Roč. 10, č. 6, rok 2015
|
|---|
| ISSN | 1336-8176
|
|---|
| Issue data | Bratislava : SOLEN, 2015
|
|---|
| Phys.des. | s. 345-410 + 1 voľná príloha
|
|---|
| Collective Record/Entry | Onkológia
|
|---|
|
|
|---|
| Language | Slovak
|
|---|
| Country | Slovakia
|
|---|
| Copy count | 2, currently available 0, at library only 2
|
|---|
| Database | PERIODIKÁ - Prijaté čísla
|
|---|
| Content | Adenokarcinóm pankreasu a diabetes mellitus = Pancreatic adenocarcinoma and diabetes mellitus / / Tatiana Novotná
|
|---|
| Úloha chemorádioterapie u starších pacientov s malobunkovým karcinómom pľúc v limitovanom štádiu = Role of chemoradiotherapy in elderly patients with limited-stage.. / Peter Beržinec
|
|---|
| Liečba ALK-pozitívneho nemalobunkového karcinómu pľúc ceritinibom - názor panelu expertov = The treatment of ALK-positive NSCLC ceritinib - view panel of experts / / Peter Beržinec, Peter Kasan
|
|---|
| Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey / / Dunscombe P., Dubinsky P. ... [et..
|
|---|
| Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with.. / Harrington K., Dubinsky P. ... [et..
|
|---|
| Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses / / Brodowicz T., Spanik S. ... [et..
|
|---|
| Malignant transformation of teratoma to adenocarcinoma with complete remission with all-trans retinoic acid-based treatment and surgery / / Chovanec M. ... [et al.]
|
|---|
| Phase II study of everolimus in refractory testicular germ cell tumors / / Mego M. ... [et al.]
|
|---|
| Prognostic value of programmed-death-1 receptor (PD-1) and its ligand (PD-L1) in testicular germ cell tumors / / Cierna Z. ... [et al.]
|
|---|
| Správa z Best of ASCO® Slovakia 2015 / / Mária Rečková
|
|---|
| Správa z bratislavských onkologických dní, LII. ročník, 8. - 9. október 2015
|
|---|
| Zodpovednosť za škodu pri poskytovaní zdravotnej starosltivosti = Liability for damages in medical field / / Tomáš Husovský, Ivan Humeník
|
|---|
| Bevacizumab v liečbe pacientok s karcinómom vaječníka v NOÚ = Bevacizumab in the treatment of patients with ovarian carcinoma / / Tomáš Minárik ... [et al.]
|
|---|
| Onkologická rehabilitácia = Cancer rehabilitation / / Eva Siracká, Lucia Budáčová
|
|---|
| Myelofibróza - diagnostika, manažment, nové liečebné možnosti = Myelofibrosis - diagnosis, management, new treatment options / / Anna Vallová
|
|---|
| Nádorová heterogenita a chemorezistencia = Tumor heterogeneity and drug resistance / / Lucia Kučerová, Svetlana Školeková,..
|
|---|
| Double-hit difuzní velkobuněčný B-lymfom = Double-hit diffuse large B-cell lymphoma / / Ján Hudeček
|
|---|
| Liečba nemalobunkového karcinómu pľúc s ALK prestavbou = Treatment of ALK-rearranged non-small cell lung cancer / / Zuzana Pribulová
|
|---|
| Inhibítory imunitných kontrolných bodov v systémovej liečbe nemalobunkového karcinómu pľúc = Immune checkpoint inhibitors in non-small cell lung cancer therapy / / Mária Černá
|
|---|
| Zvládnutá hypertenzná kríza indukovaná bevacizumabom u pacientky s metastatickým pľúcnym adenokarcinómom = Managed hypertensive crisis induced by bevacizumab in patient.. / Klaudia Grácová, Lucia Doláková
|
|---|
| Molekulárne testovanie karcinómu pľúc v SR - pohľad z klinickej praxe = Lung cancer molecular testing in Slovak Republic - view clinical practise / / Peter Beržinec ... [et al.]
|
|---|
